These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23070478)
1. Plasma clots gelled by different amounts of calcium for stem cell delivery. Gessmann J; Seybold D; Peter E; Schildhauer TA; Köller M Langenbecks Arch Surg; 2013 Jan; 398(1):161-7. PubMed ID: 23070478 [TBL] [Abstract][Full Text] [Related]
2. Fibrin Clots Maintain the Viability and Proliferative Capacity of Human Mesenchymal Stem Cells: An In Vitro Study. Warth RJ; Shupe PG; Gao X; Syed M; Lowe WR; Huard J; Harner CD Clin Orthop Relat Res; 2020 Mar; 478(3):653-664. PubMed ID: 31842142 [TBL] [Abstract][Full Text] [Related]
3. Osteogenic differentiation of human mesenchymal stromal cells is promoted by a leukocytes containing fibrin matrix. Seybold D; Schildhauer TA; Gessmann J; Muhr G; Köller M; Roetman B Langenbecks Arch Surg; 2010 Aug; 395(6):719-26. PubMed ID: 20087746 [TBL] [Abstract][Full Text] [Related]
4. Peripheral Blood Plasma Clot as a Local Antimicrobial Drug Delivery Matrix. Gessmann J; Seybold D; Ayami F; Peter E; Baecker H; Schildhauer TA; Köller M Tissue Eng Part A; 2018 May; 24(9-10):809-818. PubMed ID: 29096582 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. O'Rourke B; Nguyen S; Tilles AW; Bynum JA; Cap AP; Parekkadan B; Barcia RN Stem Cells Transl Med; 2021 Jun; 10(6):883-894. PubMed ID: 33527780 [TBL] [Abstract][Full Text] [Related]
6. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots. Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724 [TBL] [Abstract][Full Text] [Related]
7. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure. Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084 [TBL] [Abstract][Full Text] [Related]
8. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. Taylor FB; Müller-Eberhard HJ J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913 [TBL] [Abstract][Full Text] [Related]
9. 17β-estradiol improves the efficacy of exploited autologous bone marrow-derived mesenchymal stem cells in non-union radial defect healing: A rabbit model. Zamani Mazdeh D; Mirshokraei P; Emami M; Mirshahi A; Karimi I Res Vet Sci; 2018 Jun; 118():11-18. PubMed ID: 29334646 [TBL] [Abstract][Full Text] [Related]
10. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA). Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156 [TBL] [Abstract][Full Text] [Related]
11. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation. Carr ME; Martin EJ; Carr SL Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932 [TBL] [Abstract][Full Text] [Related]
12. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots. De Clerck F; Borgers M; de Gaetano G; Vermylen J Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554 [TBL] [Abstract][Full Text] [Related]
14. Determination of prothombinase activation after adding human purified prothrombin to human clot: comparison of hirudin, an activated factor II inhibitor, with DX9065a, an activated factor X inhibitor, on clot-associated thrombin and on prothrombin activation. Meddahi S; Bara L; Fessi H; Samama MM Blood Coagul Fibrinolysis; 2005 Mar; 16(2):125-33. PubMed ID: 15741800 [TBL] [Abstract][Full Text] [Related]
15. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA; Cox LM; Bouma BN Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866 [TBL] [Abstract][Full Text] [Related]